Aethlon Medical (AEMD) Stock Statistics & Valuation Metrics

Aethlon Medical has a market cap or net worth of $4.58M. The enterprise value is -$3.24M.

Aethlon Medical has 2,370,560 shares outstanding. The number of shares has decreased by -2.65% in one year.

Aethlon Medical’s return on equity (ROE) is -1.46 and return on invested capital (ROIC) is -139.64%.

The current PE Ratio of Aethlon Medical is ―. Aethlon Medical’s PEG ratio is 0.00236.

In the last 12 months, Aethlon Medical had revenue of 0.00 and earned -7.15M in profits. Earnings per share was -10.61.

In the last 12 months, operating cash flow was -6.99T and capital expenditures -3.70B, giving a free cash flow of -7.00T billion.

Aethlon Medical pays an annual dividend of ―, resulting in a dividend yield of ―

Aethlon Medical upcoming earnings date is Aug 12, 2026, After Close (Confirmed).

Aethlon Medical as a current ratio of 3.85, with Debt / Equity ratio of 6.89%

In the past 12 months, Aethlon Medical has paid 0.00 in taxes.

Aethlon Medical EV to EBITDA ratio is 0.47, with an EV/FCF ratio of <0.01.

Aethlon Medical has $5.03M in cash and marketable securities with $336.72K in debt, giving a net cash position of $4.69M billion.

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for Aethlon Medical is $2.00, which is 11.43% higher than the current price. The consensus rating is Hold